Ulipristal Drug Interactions
Currently displaying 117 drugs known to have a moderate interaction with ulipristal.
Moderate interactions with ulipristal
Note: Showing generic names only.
A
- abametapir topical
- adagrasib
- afatinib
- aliskiren
- ambrisentan
- aminoglutethimide
- amobarbital
- apixaban
- armodafinil
- artesunate
B
C
D
- dabigatran
- daunorubicin
- daunorubicin liposomal
- deferasirox
- digoxin
- docetaxel
- doxorubicin
- doxorubicin liposomal
- drospirenone
E
- echinacea
- elafibranor
- elagolix
- epirubicin
- erlotinib
- eslicarbazepine
- etonogestrel
- etoposide
- everolimus
F
G
I
L
- lapatinib
- larotrectinib
- lenacapavir
- lenalidomide
- lesinurad
- levonorgestrel
- lonafarnib
- lonapegsomatropin
- loperamide
- lusutrombopag
M
- maraviroc
- mavacamten
- mavorixafor
- medroxyprogesterone
- mephobarbital
- metreleptin
- mitapivat
- mitoxantrone
- mobocertinib
- morphine
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- pentobarbital
- phenylbutazone
- pirtobrutinib
- pitolisant
- pralsetinib
Q
R
- ranolazine
- relugolix
- ribociclib
- rifaximin
- riociguat
- ripretinib
- ritlecitinib
- rivaroxaban
- romidepsin
- rucaparib
- rufinamide
S
T
- talazoparib
- tazemetostat
- tecovirimat
- telotristat
- terfenadine
- ticagrelor
- tipranavir
- tolvaptan
- topotecan
- trofinetide
- troglitazone
- tucatinib
U
V
Ulipristal disease interactions
There are 2 disease interactions with ulipristal which include:
More about ulipristal
- ulipristal consumer information
- Check interactions
- Compare alternatives
- Reviews (782)
- Side effects
- Dosage information
- During pregnancy
- Drug class: progesterone receptor modulators
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.